PUREVAX Recombinant FeLV by Merial contains a non-adjuvanted lyophilized suspension of a recombinant vectored feline leukemia vaccine plus sterile water diluent. A canarypox vector has been modified, using recombinant technology, to produce expression of desired antigens capable of stimulating a protective immune response to feline leukemia. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible cats.
The only non-adjuvanted vaccine which means less inflammation that has been associated with the development of fibrosarcomas.
PUREVAX Recombinant FeLV Indications
PUREVAX® Recombinant FeLV is recommended for the vaccination of healthy cats 8 weeks of age or older as an aid in the prevention of disease due to feline leukemia virus.
Aseptically rehydrate the lyophilized vaccine with 1 mL of the accompanying sterile water diluent, and agitate. Administer 1 mL (1 dose) subcutaneously. For primary vaccination, cats should receive two 1-mL dose vaccinations, three weeks apart. Annual revaccination is recommended. Diagnostic testing for FeLV prior to vaccination is recommended.
All vaccines are shipped overnight. A $29.95 flat rate fee is charged for all orders containing vaccines. Someone should be present to sign for and receive the vaccine order when it ships to you. For more shipping info click here.
DISCLAIMER: The results described on the testimonials on this site, are the individual experiences and personal opinions of those who have purchased and used the products. These testimonials are not intended to make any claims that the products can be used to diagnose, treat, mitigate, cure or prevent any disease or medical condition.